163
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs

, , , , , , , , , , , , & show all
Pages 1507-1509 | Received 21 May 2014, Accepted 09 Aug 2014, Published online: 07 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tamar Tadmor. (2015) Do lymphocytes count in myeloma? Are we absolutely sure?. Leukemia & Lymphoma 56:5, pages 1193-1194.
Read now

Articles from other publishers (4)

Liu Zhaoyun & Fu Rong. (2021) Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients. Frontiers in Immunology 12.
Crossref
Chuanying Geng, Guangzhong Yang, Huijuan Wang, Zhiyao Zhang, Huixing Zhou & Wenming Chen. (2021) The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma. BioMed Research International 2021, pages 1-9.
Crossref
Yanjie Li, Hujun Li, Wenjing Li, Lijin Wang, Zhiling Yan, Yao Yao, Ruosi Yao, Kailin Xu & Zhenyu Li. (2017) Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma. Journal of Clinical Laboratory Analysis 31:5, pages e22107.
Crossref
T Dosani, F Covut, R Beck, J J Driscoll, M de Lima & E Malek. (2017) Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma. Blood Cancer Journal 7:6, pages e579-e579.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.